» Articles » PMID: 29551005

Chikungunya, Dengue, and Zika in Immunocompromised Hosts

Overview
Date 2018 Mar 19
PMID 29551005
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Describe the characteristics of chikungunya, dengue, and Zika in transplant recipients and immunocompromised hosts.

Recent Findings: Stem cell/bone marrow grafts, organs, and blood transfusions can transmit CHIKV/DENV/ZIKV infections, which are clinically similar, resembling influenza-like illness. Laboratory confirmation is necessary. In the acute phase, RT-PCR is preferred. DENV and ZIKV serology may cross-react. Delayed engraftment and extended viruria is observed in ZIKV+/HSCT recipients, while longer viremia is observed in DENV+/HSCT patients. Arbovirus persistence in organ tissues is generally unknown. Vaccine development is in early stages for CHIKV/ZIKV. No data is available to recommend the licensed DENV vaccine in transplant recipients. In endemic areas, the assessment of epidemiological risk is mandatory. Donor deferral for 120 days in suspected or confirmed ZIKV+ has been recommended, while CHIKV+ donors should wait 30 days. No deferral is recommended for DENV+ donors. CHIKV/DENV/ZIKV tests should be included in the differential of febrile neutropenia and other transplant syndromes. Reassessment of DENV serology is urgently needed. Prospective studies are necessary to determine the impact of CHIKV/DENV/ZIKV in this special population.

Citing Articles

Dengue in patients with kidney transplant: a systematic review.

Salazar-Urbano A, Sussmann-Pena O, Guezguan-Perez J, Ortiz-Parra A, Cruz-Munoz J, Mosquera-Nino K Infez Med. 2025; 33(1):50-63.

PMID: 40071265 PMC: 11892435. DOI: 10.53854/liim-3301-5.


A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates.

Thoresen D, Matsuda K, Urakami A, Ngwe Tun M, Nomura T, Moi M J Virol. 2024; 98(5):e0023924.

PMID: 38647327 PMC: 11092354. DOI: 10.1128/jvi.00239-24.


Transfusion-Transmitted Disorders 2023 with Special Attention to Bone Marrow Transplant Patients.

Udvardy M, Illes A, Gergely L, Pinczes L, Magyari F, Simon Z Pathogens. 2023; 12(7).

PMID: 37513748 PMC: 10383292. DOI: 10.3390/pathogens12070901.


Tropical Infections in the Context of Kidney Transplantation in Latin America.

Requiao-Moura L, Daher E, Moreira Albino C, de Oliveira Brilhante S, da Silva Junior G, Costa S Am J Trop Med Hyg. 2021; 105(3):564-572.

PMID: 34181579 PMC: 8592343. DOI: 10.4269/ajtmh.19-0926.


Optimal voluntary and mandatory insect repellent usage and emigration strategies to control the chikungunya outbreak on Reunion Island.

Klein S, Foster A, Feagins D, Rowell J, Erovenko I PeerJ. 2020; 8:e10151.

PMID: 33362952 PMC: 7750003. DOI: 10.7717/peerj.10151.


References
1.
Basile K, Kok J, Dwyer D . Zika virus: what, where from and where to?. Pathology. 2017; 49(7):698-706. DOI: 10.1016/j.pathol.2017.08.002. View

2.
Siu R, Bukhari W, Todd A, Gunn W, Huang Q, Timmings P . Acute Zika infection with concurrent onset of Guillain-Barré Syndrome. Neurology. 2016; 87(15):1623-1624. DOI: 10.1212/WNL.0000000000003038. View

3.
Nogueira M, Estofolete C, Terzian A, Mascarin do Vale E, da Silva R, Silva R . Zika Virus Infection and Solid Organ Transplantation: A New Challenge. Am J Transplant. 2016; 17(3):791-795. DOI: 10.1111/ajt.14047. View

4.
Styczynski J, Hoek J, Knelange N, Mikulska M, Cesaro S, Aljurf M . No report on Zika virus infection in EBMT registry: Infectious Diseases Working Party statement. Bone Marrow Transplant. 2017; 52(9):1345-1346. DOI: 10.1038/bmt.2017.145. View

5.
. Zika virus outbreaks in the Americas. Wkly Epidemiol Rec. 2015; 90(45):609-10. View